State Ledger
Company profile

Biomea Fusion, Inc. CIK 1840439

Ticker
BMEA (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Carlos, CA 94070
Fiscal year end
2025 (FY)
Market Data
Close
$1.37
Change
-$0.05
Change %
-3.19%
Volume
65,070

BMEA · trading date Oct 12, 2026 · previous close $1.41 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$61.80M
Total assets
$58.57M
Total liabilities
$29.02M
Stockholders' equity
$29.55M
Cash & equivalents
$55.81M
Operating income
-$83.51M
Operating cash flow
-$70.37M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-24. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
49.5%
Equity / assets
50.5%
CapEx / revenue
—
Operating cash flow / net income
1.14×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$61.80M $58.57M $29.02M $29.55M
2024 — -$138.43M $79.94M $28.37M $51.57M
2023 — -$117.26M $199.93M $30.69M $169.24M
2022 — -$81.83M $129.31M $20.77M $108.54M
2021 — -$41.57M $185.71M $6.92M $178.78M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-05
Financials filed via
Form 10-K
filed 2026-03-24

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Carlos, CA 94070
1599 INDUSTRIAL ROAD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies